Home

Sms Pharmaceuticals Ltd EPS

Image

SMS Pharmaceuticals Ltd

NSE: SMSPHARMA

EPS

₹ 7.81

Last updated on: Feb 21, 2025

Key Highlights

  • The Earning per Share of SMS Pharmaceuticals Ltd is ₹ 7.81 as of 21 Feb 25 .
  • The earning per share of SMS Pharmaceuticals Ltd changed from ₹ 1.1 to ₹ 2.15 over 7 quarters. This represents a CAGR of 46.66% .

Historical Earning per Share of SMS Pharmaceuticals Ltd

No data available

* All values are in

Company Fundamentals for SMS Pharmaceuticals Ltd

Market Cap

1,814 Cr

EPS

7.8

P/E Ratio (TTM)

27.5

P/B Ratio (TTM)

3.2

Day’s High

224.6

Day’s Low

204.5

DTE

0.5

ROE

10.5

52 Week High

398.0

52 Week Low

140.2

ROCE

11.8

Market Price of SMS Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring SMS Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 2025214.35
20 Feb 2025203.65
19 Feb 2025191.55
18 Feb 2025185.55
17 Feb 2025192.8
14 Feb 2025198.65
13 Feb 2025204.35
12 Feb 2025212.5
11 Feb 2025200
10 Feb 2025211.3

SWOT Analysis Of SMS Pharmaceuticals Ltd

Strength

2

che

Weakness

1

che

Opportunity

0

che

Threats

2

che

BlinkX Score for SMS Pharmaceuticals Ltd

Asset Value vs Market Value of SMS Pharmaceuticals Ltd

Market Value

1,815

Asset Value

Value addition

2.4 X

536

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
SMS Pharmaceuticals Ltd1814
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

Historical Market Cap of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of SMS Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

SMS Pharmaceuticals Ltd News Hub

SMS Pharmaceuticals to conduct AGM

SMS Pharmaceuticals announced that the Annual General Meeting (AGM) of the company will be held on 3

Read more

08 Aug 24

Board of SMS Pharmaceuticals approves incorporation of subsidiary company

The Board of SMS Pharmaceuticals at its meeting held on 05 August 2024 has approved to incorporate a

Read more

05 Aug 24

SMS Pharmaceuticals fixes record date for dividend

SMS Pharmaceuticals has fixed 23 September 2024 as record date for the purpose of determining the Me

Read more

05 Aug 24

SMS Pharmaceuticals consolidated net profit rises 76.45% in the June 2024 quarter

Net profit of SMS Pharmaceuticals rose 76.45% to Rs 16.48 crore in the quarter ended June 2024 as ag

Read more

05 Aug 24

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for EPS of SMS Pharmaceuticals Ltd

What is the EPS of SMS Pharmaceuticals Ltd stock?

The Earnings Per Share (EPS) of SMS Pharmaceuticals Ltd is 7.81. An EPS is the amount of net income attributed to each share of a common stock.

How is SMS Pharmaceuticals Ltd EPS calculated?

The EPS of SMS Pharmaceuticals Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does SMS Pharmaceuticals Ltd report its EPS?

SMS Pharmaceuticals Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence SMS Pharmaceuticals Ltd EPS?

Factors that influence the EPS of SMS Pharmaceuticals Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can SMS Pharmaceuticals Ltd EPS growth indicate future performance?

Yes, consistent growth in SMS Pharmaceuticals Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions